Glorieux G - Search Results

1

Levels of Indoxyl Sulfate in Kidney Transplant Patients, and the Relationship With Hard Outcomes.

Liabeuf S, Desjardins L, Massy ZA, Brazier F, Westeel PF, Mazouz H, Titeca-Beauport D, Diouf M, Glorieux G, Vanholder R, Jaureguy M, Choukroun G. Liabeuf S, et al. Among authors: glorieux g. Circ J. 2016;80(3):722-30. doi: 10.1253/circj.CJ-15-0949. Epub 2016 Feb 4. Circ J. 2016. PMID: 26841804 Free article.

2

The other side of the coin: impact of toxin generation and nutrition on the uremic syndrome.

Vanholder R, Glorieux G, Lameire N. Vanholder R, et al. Among authors: glorieux g. Semin Dial. 2002 Sep-Oct;15(5):311-4. doi: 10.1046/j.1525-139x.2002.00076.x. Semin Dial. 2002. PMID: 12358630

3

Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis.

Jacobs P, Glorieux G, Vanholder R. Jacobs P, et al. Among authors: glorieux g. Nephrol Dial Transplant. 2004 Aug;19 Suppl 5:V41-45. doi: 10.1093/ndt/gfh1055. Nephrol Dial Transplant. 2004. PMID: 15284359 Review.

4

What is new in uremic toxicity?

Vanholder R, Van Laecke S, Glorieux G. Vanholder R, et al. Among authors: glorieux g. Pediatr Nephrol. 2008 Aug;23(8):1211-21. doi: 10.1007/s00467-008-0762-9. Epub 2008 Mar 7. Pediatr Nephrol. 2008. PMID: 18324423 Free PMC article. Review.

5

The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity?

Vanholder R, Van Laecke S, Glorieux G. Vanholder R, et al. Among authors: glorieux g. J Nephrol. 2008 Mar-Apr;21(2):146-60. J Nephrol. 2008. PMID: 18446708 Review.

6

An overview of uremic toxicity.

Vanholder RC, Glorieux GL. Vanholder RC, et al. Hemodial Int. 2003 Apr 1;7(2):156-61. doi: 10.1046/j.1492-7535.2003.00034.x. Hemodial Int. 2003. PMID: 19379356

7

Uremic toxins: removal with different therapies.

Vanholder RC, Glorieux GL, De Smet RV. Vanholder RC, et al. Hemodial Int. 2003 Apr 1;7(2):162-7. doi: 10.1046/j.1492-7535.2003.00033.x. Hemodial Int. 2003. PMID: 19379357

8

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uremic Toxin Work Group (EUTox). Barreto FC, et al. Among authors: glorieux g. Clin J Am Soc Nephrol. 2009 Oct;4(10):1551-8. doi: 10.2215/CJN.03980609. Epub 2009 Aug 20. Clin J Am Soc Nephrol. 2009. PMID: 19696217 Free PMC article.

9

Platelet/Leukocyte activation, inflammation, and uremia.

Glorieux G, Cohen G, Jankowski J, Vanholder R. Glorieux G, et al. Semin Dial. 2009 Jul-Aug;22(4):423-7. doi: 10.1111/j.1525-139X.2009.00593.x. Semin Dial. 2009. PMID: 19708994 Review.

10

Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease.

Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uraemic Toxin Work Group (EUTox). Liabeuf S, et al. Among authors: glorieux g. Nephrol Dial Transplant. 2010 Apr;25(4):1183-91. doi: 10.1093/ndt/gfp592. Epub 2009 Nov 13. Nephrol Dial Transplant. 2010. PMID: 19914995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page